1.
Cureus
; 13(7): e16746, 2021 Jul.
Artículo
en Inglés
| MEDLINE
| ID: mdl-34513370
RESUMEN
On January 30, 2020, the World Health Organization (WHO) declared the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic a worldwide emergency. Worldwide there have been 170 million cases of the resulting disease coronavirus 2019 (COVID-19), of those, 3.53 million have resulted in death. The Food and Drug Administration (FDA) with Mayo Clinic as the lead institution authorized COVID-19 convalescent plasma (CCP) for treatment of SARS-CoV-2 infection. Effective therapeutic window for CCP administration had yet to be defined. We addressed this gap by characterizing longitudinal biologic response and clinical outcomes of COVID-19 patients treated with CCP. Primary outcome was discharged to home/home health.
2.
Am J Med
; 132(8): 995-1000, 2019 08.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31051147
3.
Am J Med
; 132(7): 886-891, 2019 07.
Artículo
en Inglés
| MEDLINE
| ID: mdl-30953633